Malek, Alexandre E.
Al-Juhaishi, Taha http://orcid.org/0000-0002-8359-0178
Milton, Denái R.
Ramdial, Jeremy L. http://orcid.org/0000-0002-8984-3420
Daher, May
Olson, Amanda L. http://orcid.org/0000-0002-1669-0355
Srour, Samer A.
Alatrash, Gheath
Oran, Betul
Mehta, Rohtesh S. http://orcid.org/0000-0002-8532-544X
Khouri, Issa F. http://orcid.org/0000-0003-2473-911X
Bashir, Qaiser http://orcid.org/0000-0002-4086-6453
Shah, Nina
Ciurea, Stefan O.
Rondon, Gabriela
Maadani, Farzaneh
Hosing, Chitra
Marin, David
Kebriaei, Partow http://orcid.org/0000-0002-8607-9404
Rezvani, Katayoun
Nieto, Yago
Anderlini, Paolo
Alousi, Amin M. http://orcid.org/0000-0002-2498-8573
Faisal, Muhammad Salman
Qazilbash, Muzaffar H. http://orcid.org/0000-0003-2876-2886
Popat, Uday R. http://orcid.org/0000-0002-7592-2224
Champlin, Richard E. http://orcid.org/0000-0002-4314-5037
Shpall, Elizabeth J.
Mulanovich, Victor E. http://orcid.org/0000-0001-7028-4860
Ahmed, Sairah http://orcid.org/0000-0001-7302-8299
Article History
Received: 30 July 2023
Revised: 29 January 2024
Accepted: 31 January 2024
First Online: 14 February 2024
Competing interests
: SC declares Advisory board: Hansa Therapeutics, CareDx, Achrotech, Kiadis Pharma, Allogene, Celularity, MolMed, Phamacyclics; Research funds from Miltenyi Biotech, Kiadis Pharma. GR declares consulting agreement with Omeros Pharma. SA declares research support to institution for clinical trials from Seattle Genetics, Merck, Xencor, Chimagen and Tessa Therapeutics, has membership on Tessa Therapeutic’s and Chimagen scientific advisory committee, she serves on Data Safety Monitoring Board for Myeloid Therapeutics; she is a consultant for ADC therapeutics, KITE/Gilead.